DONNA VALENTINE: Open Payments
NPI 1801995410 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$539 in 18 payments from 13 companies in 2025. Trend: 2023 $1,901 · 2024 $3,700 · 2025 $539
Food & beverage: $539
| Company | Payments | Amount |
|---|---|---|
| INTUITIVE SURGICAL, INC. | 1 | $131 |
| ABBVIE INC. | 3 | $76 |
| Celgene Corporation | 3 | $72 |
| SOBI, INC | 2 | $48 |
| BeiGene USA, Inc. | 1 | $30 |
| Stemline Therapeutics Inc. | 1 | $28 |
| Fennec Pharmaceuticals, Inc. | 1 | $25 |
| Gilead Sciences, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Incyte Corporation | 1 | $24 |
Products named: Da Vinci Surgical System, EPKINLY, Vonjo, REBLOZYL, OPDIVO, BRUKINSA, ELZONRIS, Fyarro.
Industry payments across CA — which companies pay providers there.
